Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 32.660
- -1.650-4.81%
Close Dec 13 16:00 ET
- 32.660
- 0.0000.00%
Post 20:02 ET
2.14BMarket Cap-16.84P/E (TTM)
34.400High32.410Low1.45MVolume34.000Open34.310Pre Close48.39MTurnover2.23%Turnover RatioLossP/E (Static)65.68MShares53.69052wk High9.02P/B2.13BFloat Cap21.85052wk Low--Dividend TTM65.14MShs Float302.500Historical High--Div YieldTTM5.80%Amplitude2.140Historical Low33.329Avg Price1Lot Size
Tandem Diabetes Care Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48,589.09%26.78M | 16.57%-5.28M | 56.37%-8M | -163.04%-31.81M | -223.99%-7.22M | -99.77%55K | -191.62%-6.32M | -232.80%-18.33M | -54.68%50.46M | -70.36%5.82M |
| Net income from continuing operations | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M | -741.81%-123.87M | -707.70%-94.59M | -246.68%-15.85M |
| Operating gains losses | --0 | --0 | --1.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 4.67%4.21M | -3.68%4.11M | 19.05%4.04M | 9.67%15.72M | 10.71%4.03M | 14.68%4.02M | 20.04%4.27M | -6.39%3.4M | 3.50%14.33M | 3.44%3.64M |
| Other non cash items | 98.47%-223K | -80.90%2.72M | -99.12%702K | 130.34%95.57M | 70.10%16.54M | -147.41%-14.55M | 7,197.95%14.23M | 8,999.43%79.35M | 905.57%41.49M | 227.92%9.73M |
| Change In working capital | 153.05%15.13M | 44.35%-8.49M | 5,671.59%4.9M | -280.40%-17.69M | 53.79%-8.32M | -56.66%5.98M | -231.86%-15.26M | -102.12%-88K | -132.35%-4.65M | -24.57%-17.99M |
| -Change in receivables | -214.43%-11.57M | 25.71%-6.9M | -57.26%9.77M | 154.62%4.28M | -84.41%-5.6M | 62.12%-3.68M | 14.02%-9.29M | 45.24%22.85M | 74.73%-7.83M | 87.47%-3.03M |
| -Change in inventory | 221.02%10.37M | 48.13%-8.31M | 115.85%3.16M | -8.48%-46.05M | -147.48%-13.34M | 119.34%3.23M | -91.07%-16.03M | -66.48%-19.92M | -756.92%-42.45M | -78.24%-5.39M |
| -Change in prepaid assets | 132.66%1.36M | -132.90%-678K | 21.20%-4.1M | -15,656.90%-9.14M | -29.61%-1.84M | -2,493.13%-4.15M | 163.22%2.06M | -802.83%-5.21M | 96.31%-58K | -0.64%-1.42M |
| -Change in payables and accrued expense | 88.22%-1.19M | -44.26%3.61M | -266.59%-3.37M | -109.68%-2.33M | 156.09%2.25M | -229.14%-10.13M | 0.23%6.48M | -106.69%-919K | 61.13%24.03M | -198.65%-4.01M |
| -Change in other current assets | -21.67%347K | 125.84%329K | 38.86%-236K | -164.04%-3.19M | -697.98%-1.97M | 850.85%443K | -299.06%-1.27M | 33.68%-386K | -191.93%-1.21M | -116.84%-247K |
| -Change in other current liabilities | -51.21%2.38M | -3.54%3.16M | -38.30%1.72M | 18.69%17.22M | 157.88%6.27M | -72.84%4.89M | -62.99%3.28M | 285.77%2.78M | -42.05%14.51M | -157.36%-10.84M |
| -Change in other working capital | -12.64%13.43M | 163.13%303K | -383.36%-2.03M | 157.54%21.53M | -14.87%5.91M | 5.29%15.38M | 59.43%-480K | 105.95%715K | -21.23%8.36M | 167.93%6.95M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48,589.09%26.78M | 16.57%-5.28M | 56.37%-8M | -163.04%-31.81M | -223.99%-7.22M | -99.77%55K | -191.62%-6.32M | -232.80%-18.33M | -54.68%50.46M | -70.36%5.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 59.00%-19.9M | -162.13%-3.54M | 80.80%-5.06M | -358.50%-85.74M | -146.35%-16.58M | -242.62%-48.53M | -10.37%5.7M | -606.62%-26.33M | 117.75%33.17M | 146.57%35.78M |
| Net PPE purchase and sale | 2.98%-5.24M | 12.35%-6.47M | 49.51%-4.46M | 21.39%-26.8M | 7.61%-5.2M | 60.61%-5.4M | 39.12%-7.38M | -234.01%-8.83M | -140.46%-34.1M | 2.07%-5.63M |
| Net intangibles purchase and sale | --0 | --0 | --0 | -180.06%-24.8M | ---22.28M | --0 | ---515K | ---2M | 5.10%-8.86M | --0 |
| Net business purchase and sale | --0 | --0 | --0 | -170.20%-69.5M | --0 | --0 | --0 | ---69.5M | ---25.72M | ---23K |
| Net investment purchase and sale | 66.01%-14.66M | -78.47%2.93M | -101.11%-599K | -65.28%35.36M | -73.69%10.9M | -228.41%-43.13M | -28.43%13.59M | 588.71%54M | 162.34%101.84M | 158.29%41.43M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 59.00%-19.9M | -162.13%-3.54M | 80.80%-5.06M | -358.50%-85.74M | -146.35%-16.58M | -242.62%-48.53M | -10.37%5.7M | -606.62%-26.33M | 117.75%33.17M | 146.57%35.78M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -136.47%-4.52M | -176.04%-3M | 2,611.28%13.59M | -75.63%4.11M | -57.10%2.62M | -146.90%-1.91M | -50.96%3.95M | -115.46%-541K | -67.50%16.88M | -61.60%6.1M |
| Net issuance payments of debt | --0 | --0 | --60.73M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | --0 | --0 | ---30M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -145.60%-4.52M | -176.04%-3M | -179.30%-1.51M | -76.16%4.18M | -57.10%2.62M | -398.64%-1.84M | -52.55%3.95M | -115.46%-541K | -66.20%17.55M | -61.60%6.1M |
| Net other financing activities | --0 | --0 | ---15.63M | 89.48%-71K | --0 | ---- | ---- | ---- | ---675K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -136.47%-4.52M | -176.04%-3M | 2,611.28%13.59M | -75.63%4.11M | -57.10%2.62M | -146.90%-1.91M | -50.96%3.95M | -115.46%-541K | -67.50%16.88M | -61.60%6.1M |
| Net cash flow | ||||||||||
| Beginning cash position | -63.52%47.7M | -53.84%58.98M | -65.88%58.87M | 142.36%172.52M | -35.69%79.61M | 13.73%130.75M | 36.38%127.76M | 142.36%172.52M | -24.77%71.18M | 10.15%123.79M |
| Current changes in cash | 104.69%2.36M | -455.61%-11.82M | 101.18%534K | -212.86%-113.44M | -144.41%-21.18M | -659.42%-50.38M | -84.41%3.32M | -300.90%-45.2M | 526.16%100.51M | 215.50%47.7M |
| Effect of exchange rate changes | -34.65%-1.02M | 260.18%535K | -195.92%-423K | -125.63%-212K | -57.45%440K | -308.06%-759K | -1,291.67%-334K | 14,600.00%441K | 440.52%827K | 903.88%1.03M |
| End cash Position | -38.40%49.04M | -63.52%47.7M | -53.84%58.98M | -65.88%58.87M | -65.88%58.87M | -35.69%79.61M | 13.73%130.75M | 36.38%127.76M | 142.36%172.52M | 142.36%172.52M |
| Free cash flow | 502.99%21.54M | 17.40%-11.74M | 57.29%-12.45M | -1,210.40%-83.41M | -18,078.76%-34.7M | -382.36%-5.35M | -148.04%-14.22M | -361.31%-29.15M | -91.45%7.51M | -98.61%193K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.